➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Moodys
Johnson and Johnson
Dow
Colorcon

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

VALACYCLOVIR HYDROCHLORIDE Drug Profile


Email this page to a colleague

« Back to Dashboard

When do Valacyclovir Hydrochloride patents expire, and when can generic versions of Valacyclovir Hydrochloride launch?

Valacyclovir Hydrochloride is a drug marketed by Apotex, Atlantide, Aurobindo Pharma, Cipla, Hetero Labs Ltd V, Hikma, Jubilant Generics, Mylan, Mylan Pharms Inc, Sandoz, Sun Pharm Inds Ltd, Teva Pharms, Time-cap Labs Inc, Watson Labs Inc, Yiling, and Zydus Pharms. and is included in sixteen NDAs.

The generic ingredient in VALACYCLOVIR HYDROCHLORIDE is valacyclovir hydrochloride. There are twenty-three drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the valacyclovir hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Valacyclovir Hydrochloride

A generic version of VALACYCLOVIR HYDROCHLORIDE was approved as valacyclovir hydrochloride by SUN PHARM INDS LTD on January 31st, 2007.

  Get Started Free

Drug patent expirations by year for VALACYCLOVIR HYDROCHLORIDE
Recent Clinical Trials for VALACYCLOVIR HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alzheimer's AssociationPhase 2
University of Maryland, BaltimorePhase 4
University of Alabama at BirminghamPhase 1

See all VALACYCLOVIR HYDROCHLORIDE clinical trials

Paragraph IV (Patent) Challenges for VALACYCLOVIR HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
VALTREX TABLET;ORAL valacyclovir hydrochloride 020487

US Patents and Regulatory Information for VALACYCLOVIR HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 079137-001 Dec 29, 2017 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Watson Labs Inc VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 090370-001 Mar 16, 2011 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Yiling VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 209553-002 Mar 18, 2020 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts
Baxter
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.